NeuroSense Therapeutics NRSN
NASDAQ NRSN
$2.56 +0.17 (+7.11%)
At close: Oct 21, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) EBT (2021 - 2024)

Updated

NeuroSense Therapeutics' EBT was -$11.09 million in FY2025, compared with -$9.9 million in FY2024.

Analysis

NeuroSense Therapeutics (NRSN) EBT (2021 - 2024) Analysis & Trends

From FY2019 onward, NeuroSense Therapeutics has reported EBT for 7 years.

  • The FY2025 figure marks the lowest annual EBT in data going back to FY2019.
  • Per Business Quant data, EBT in earlier years was -$9.9 million in FY2024, -$5.61 million in FY2023, -$9.25 million in FY2022 and $933,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 9.25 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 6.75 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 4.28 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -683.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 4.27 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.80 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 2.77 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -10.25 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -653.00 Mn
10 NeuroSense Therapeutics 3.19 Mn -1.26 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -1.77 Mn
Sep 30, 2024 -2.11 Mn
Jun 30, 2024 -3.03 Mn
Mar 31, 2024 -2.99 Mn
Dec 31, 2023 -7.14 Mn
Sep 30, 2023 5.47 Mn
Jun 30, 2023 -5.74 Mn
Mar 31, 2023 -2.62 Mn
Dec 31, 2022 -288,000.00
Sep 30, 2022 -2.86 Mn
Jun 30, 2022 -3.53 Mn
Mar 31, 2022 -2.67 Mn
Dec 31, 2021 2.50 Mn
API Access

NeuroSense Therapeutics EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=NRSN&period=max&api_key=YOUR_API_KEY